{"groups":[{"description":"* Day 1: Mobilization with 240 mcg/kg SC AMD3100 and leukopheresis\n* If PBSC collected are not adequate, then donor will again be mobilized with AMD3100 and have leukopheresis collection on day 3.","id":"FG000","title":"Subcutaneous (SC) Treatment Plan - Donor"},{"description":"* Conditioning Regimen\n\n  * Cyclophosphamide 60mg/kg/day on Days -3 and -2\n  * TBI 550cGy on Day -1\n* GVHD prophylaxis\n\n  \\*Cyclosporin 3.0mg/kg/day beginning on Day -1 then tapered through Day +100\n* PBSC transplant on Day 0","id":"FG001","title":"Recipients"},{"description":"* Day -3: Mobilization with 80-480 mcg/kg/day IV AMD3100 and PK analysis\n* Day 1: Mobilization with 240 mcg/kg/day SC AMD3100 and leukopheresis\n* If PBSC collected are not adequate, then donor will again be mobilized with AMD3100 and have leukopheresis collection on day 3.","id":"FG002","title":"Intravenous (IV) Treatment Plan - Donor"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"1"},{"groupId":"FG002","numSubjects":"1"}],"type":"Determined to be not ineligible"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"25"},{"groupId":"FG001","numSubjects":"46"},{"groupId":"FG002","numSubjects":"21"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"25"},{"groupId":"FG001","numSubjects":"45"},{"groupId":"FG002","numSubjects":"20"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"1"},{"groupId":"FG002","numSubjects":"1"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}],"recruitmentDetails":"The study was opened to participant enrollment on 05/14/2004 and closed to participant enrollment on 01/26/2009."}